Harrow (HROW) FCF Margin Growth (1y) (2014 - 2026)
Harrow (HROW) FCF Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 427.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 325.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -892.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 1,003.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 410.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 39.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 333.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Harrow | 1.53 Bn | 1.45 Bn | 50.36 Mn | -1,298.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,298.00 |
| Mar 31, 2026 | -6,155.00 |
| Dec 31, 2025 | 3,778.00 |
| Sep 30, 2025 | 1,685.00 |
| Jun 30, 2025 | 432.00 |
| Mar 31, 2025 | 5,440.00 |
| Dec 31, 2024 | -5,211.00 |
| Sep 30, 2024 | 1,261.00 |
| Jun 30, 2024 | -2,030.00 |
| Mar 31, 2024 | 1,973.00 |
| Dec 31, 2023 | 4,596.00 |
| Sep 30, 2023 | -47.00 |
| Jun 30, 2023 | -494.00 |
| Mar 31, 2023 | -3,591.00 |
| Dec 31, 2022 | -1,452.00 |
| Sep 30, 2022 | 622.00 |
| Jun 30, 2022 | -394.00 |
| Mar 31, 2022 | -1,686.00 |
| Dec 31, 2021 | -362.00 |
| Sep 30, 2021 | -2,947.00 |